Bengt Sorbe

4.0k total citations
133 papers, 3.0k citations indexed

About

Bengt Sorbe is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Bengt Sorbe has authored 133 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Obstetrics and Gynecology, 57 papers in Reproductive Medicine and 47 papers in Surgery. Recurrent topics in Bengt Sorbe's work include Endometrial and Cervical Cancer Treatments (61 papers), Ovarian cancer diagnosis and treatment (56 papers) and Cervical Cancer and HPV Research (30 papers). Bengt Sorbe is often cited by papers focused on Endometrial and Cervical Cancer Treatments (61 papers), Ovarian cancer diagnosis and treatment (56 papers) and Cervical Cancer and HPV Research (30 papers). Bengt Sorbe collaborates with scholars based in Sweden, United States and Finland. Bengt Sorbe's co-authors include Ingirídur Skírnisdóttir, B. Frankendal, Karin Boman, Tomas Seidal, Caroline Lundgren, Mats G. Karlsson, Håkan Andersson, Britt‐Marie Ternestedt, Bjørn Risberg and Per Rosenberg and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Bengt Sorbe

130 papers receiving 2.9k citations

Peers

Countries citing papers authored by Bengt Sorbe

Since Specialization

Citations

This map shows the geographic impact of Bengt Sorbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Sorbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Sorbe more than expected).

Fields of papers citing papers by Bengt Sorbe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Sorbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Sorbe. The network helps show where Bengt Sorbe may publish in the future.

Co-authorship network of co-authors of Bengt Sorbe

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Sorbe. A scholar is included among the top collaborators of Bengt Sorbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Sorbe. Bengt Sorbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A comparison of external pelvic chemoradiation and high dose-rate conventional brachytherapy (BT) and image-guided adaptive brachytherapy (IGABT) in treatment of advanced cervical carcinomas 2020 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bengt Sorbe, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Combined external pelvic chemoradiotherapy and image-guided adaptive brachytherapy in treatment of advanced cervical carcinoma: experience from a single institution 2020 ·Journal of Contemporary Brachytherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bengt Sorbe	10
3	Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution 2019 ·In Vivo ·(unknown), Kjell Jansson, Bengt Sorbe	9
4	HPV-negative Tumors in a Swedish Cohort of Cervical Cancer 2019 ·International Journal of Gynecological Pathology ·(unknown), Mats G. Karlsson, Bengt Sorbe, (unknown), Gisela Helenius, Gabriella Lillsunde‐Larsson	35
5	HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma 2018 ·Papillomavirus Research ·Gabriella Lillsunde‐Larsson, (unknown), Bengt Sorbe, Gisela Helenius, Mats G. Karlsson	3
6	Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina? 2017 ·Medical Oncology ·(unknown), Bengt Sorbe, Gisela Helenius, Mats G. Karlsson, Gabriella Lillsunde‐Larsson	5
7	Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma 2017 ·PLoS ONE ·(unknown), Gabriella Lillsunde‐Larsson, Håkan Hedman, David Lindquist, Mats G. Karlsson, Ann‐Cathrin Hellström, Ellinor Östensson, Bengt Sorbe, Kristina Hellman, Sonia Andersson	8
8	Determination of the most effective cooling temperature for the prevention of chemotherapy-induced alopecia 2013 ·Molecular and Clinical Oncology ·(unknown), (unknown), (unknown), Bengt Sorbe	17
9	Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma 2012 ·ISRN Obstetrics and Gynecology ·Bengt Sorbe	18
10	External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma 2012 ·International Journal of Gynecological Cancer ·Bengt Sorbe, György Horváth, Håkan Andersson, Karin Boman, Caroline Lundgren, Birgitta Pettersson	42
11	Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studies 2010 ·European Journal of Cancer ·Thomas Högberg, Mauro Signorelli, Carlos Oliveira, Roldano Fossati, Andrea Alberto Lissoni, Bengt Sorbe, Håkan Andersson, Seija Grénman, Caroline Lundgren, Per Rosenberg, Karin Boman, Bengt Tholander, Giovanni Scambia, Nicholas Reed, Gennaro Cormio, Germana Tognon, (unknown), Tomasz Sawicki, Paolo Zola, Gunnar B. Kristensen	313
12	Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxellong-term follow-up 2007 ·International Journal of Gynecological Cancer ·Bengt Sorbe, Henrik Andersson, Karin Boman, P. Rosenberg, (unknown)	57
13	Lymph node sampling is of prognostic value in early stage epithelial ovarian carcinoma. 2005 ·PubMed ·(unknown), Bengt Sorbe	7
14	The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma 2001 ·International Journal of Gynecological Cancer ·Ingirídur Skírnisdóttir, Bengt Sorbe, (unknown)	77
15	P53, bcl-2, and bax: Their relationship and effect on prognosis in early stage epithelial ovarian carcinoma 2001 ·International Journal of Gynecological Cancer ·Ingirídur Skírnisdóttir, Bengt Sorbe, Tomas Seidal	25
16	Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting ? the Nordic experience 1994 ·Supportive Care in Cancer ·Bengt Sorbe, (unknown), (unknown), (unknown), (unknown), (unknown), Eva Tiensuu Janson, (unknown), Michael Kjær, Hanne Havsteen, (unknown), Erik Sandberg, Martti Flander, Mirja Heikkinen, (unknown)	7
17	Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: The Nordic experience 1993 ·Annals of Oncology ·Bengt Sorbe	15
18	Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of radiation-induced emesis 1992 ·Radiotherapy and Oncology ·Bengt Sorbe, (unknown), (unknown)	8
19	Prognosis of Endometrial Carcinoma Stage I in Two Swedish Regions: A study with special regard to the effects of intracavitary irradiation with high dose-rate afterloading technique or with low dose-rate radium 1990 ·Acta Oncologica ·Bengt Sorbe, Olle Kjellgren, (unknown)	4
20	Primary aneuploid lymphoma of the uterine cervix: A case report 1988 ·Gynecologic Oncology ·Peter Strang, Bengt Sorbe, Christer Sundström	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact